UPEXI, INC.
BioSniper Score
Based on 2 of 6 signals
Limited data coverage
Market Cap
$63.8M
Cash Runway
24.5 mo
Lead Asset
—
Next Catalyst
—
Go deeper on UPEXI, INC. with Spotter
Ask follow-up questions and run a full multi-agent deep dive on UPXI — live, with citations.
Score breakdownBased on 2 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
24.5 months
OCF -$5M · Net income -$109M
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
No insider transactions in the last 180 days
Key Financialsas of March 31, 2026
Cash
$3.5M
Quarterly Burn
$4.8M
Revenue
$4.6M
Free Cash Flow
-$4.8M
Total Liabilities
$252.3M
Shareholders Equity
-$51.9M
Current Ratio
1.72
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Commercialization & Governance
Commercialization
- Launch Markets
- -
- Commercial Strategy
- The Company's treasury strategy focuses on holding Solana (SOL) tokens, staking the majority of these tokens to earn yield, and utilizing intelligent capital markets issuance (equity and convertible debt) to purchase additional Solana. The Company also intends to purchase locked Solana at a discount to the spot price.
Governance
- Board Size
- 5
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
53
Total value held
$15.8M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 6,765,204 | $6.7M |
| mmcap international inc. spc | 2,326,777 | $2.3M |
| susquehanna international group, llp | 1,260,528 | $1.2M |
| jane street group, llc | 908,995 | $896K |
| osaic holdings, inc. | 775,862 | $768K |
| blackrock, inc. | 681,308 | $671K |
| geode capital management, llc | 538,517 | $531K |
| citadel advisors llc | 418,800 | $413K |
| j. derek lewis & associates inc. | 249,000 | $351K |
| vanguard fiduciary trust co | 327,983 | $323K |
Showing top 10 of 53 institutional holders of UPEXI, INC.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
Who is the CEO of UPEXI, INC.?
Mr. Allan J. Marshall is the chief executive officer of UPEXI, INC. (UPXI).
Where is UPEXI, INC. headquartered?
UPEXI, INC. (UPXI) is headquartered in Tampa, FL, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.
Get the full picture on UPEXI, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.